259
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Adolescent and Adult Correlates of Prescription Opioid Use and Misuse in Adulthood: Associations Across Domains of Despair

, , &

References

  • Becker, W. C., Dorflinger, L., Edmond, S. N., Islam, L., Heapy, A. A., & Fraenkel, L. (2017). Barriers and facilitators to use of non-pharmacological treatments in chronic pain. BMC Family Practice, 18(1), 41. https://doi.org/10.1186/s12875-017-0608-2
  • Betts, K. S., McIlwraith, F., Dietze, P., Whittaker, E., Burns, L., Cogger, S., & Alati, R. (2015). Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs? Drug Alcohol Depend, 154, 76–84. https://doi.org/10.1016/j.drugalcdep.2015.06.020
  • Blanco, C., Wall, M. M., Liu, S. -M., & Olfson, M. (2019). Toward a comprehensive developmental model of prescription opioid use disorder. The Journal of Clinical Psychiatry, 81(1), 1-7. https://doi.org/10.4088/JCP.19m12775
  • Brownstein, N. B., Wd. Tabor, J., Entzel, P., Daza, E., Mullan Harris, K. (2020). Non-response in wave IV of the national longitudinal study of adolescent to adult health. https://www.cpc.unc.edu/projects/addhealth/documentation/guides/W4_nonresponse.pdf
  • Case, A., & Deaton, A. (2015). Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proceedings of the National Academy of Sciences, 112(49), 15078–15083. https://doi.org/10.1073/pnas.1518393112
  • Centers for Disease Control and Prevention (2020). Understanding the epidemic. https://www.cdc.gov/drugoverdose/epidemic/index.html
  • Chatterjee, A., Lopez, D., Ramkellawan, S., Brown, R., Smith, K., Gaeta, J. M., & Baggett, T. P. (2019). That’s what we call the cocktail: Non-opioid medication and supplement misuse among opioid users. Substance Abuse, 1–8. https://doi.org/10.1080/08897077.2019.1671943
  • Cicero, T. J., & Ellis, M. S. (2017). Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter? Drug and Alcohol Dependence, 173, S4–S10. https://doi.org/10.1016/j.drugalcdep.2016.03.014
  • Cragg, A., Hau, J. P., Woo, S. A., Kitchen, S. A., Liu, C., Doyle-Waters, M. M., & Hohl, C. M. (2019). Risk factors for misuse of prescribed opioids: A systematic review and meta-analysis. Annals of Emergency Medicine, 74(5), 634–646. https://doi.org/10.1016/j.annemergmed.2019.04.019
  • Dasgupta, N., Beletsky, L., & Ciccarone, D. (2018). Opioid crisis: No easy fix to its social and economic determinants. American Journal of Public Health, 108(2), 182–186. https://doi.org/10.2105/AJPH.2017.304187
  • Davis, M. J., Moore, K. M., Meyers, K., Mathews, J., & Zerth, E. O. (2016). Engagement in mental health treatment following primary care mental health integration contact. Psychological Services, 13(4), 333–340. https://doi.org/10.1037/ser0000089
  • Fisher, E., Heathcote, L., Palermo, T. M., de, C., Williams, A. C., Lau, J., & Eccleston, C. (2014). Systematic review and meta-analysis of psychological therapies for children with chronic pain. Journal of Pediatric Psychology, 39(8), 763–782. https://doi.org/10.1093/jpepsy/jsu008
  • Garland, E. L., Hanley, A. W., Thomas, E. A., Knoll, P., & Ferraro, J. (2015). Low dispositional mindfulness predicts self-medication of negative emotion with prescription opioids. Journal of Addiction Medicine, 9(1), 61.
  • Haegerich, T. M., Jones, C. M., Cote, P.-O., Robinson, A., & Ross, L. (2019). Evidence for state, community and systems-level prevention strategies to address the opioid crisis. Drug and Alcohol Dependence, 204, 107563. https://doi.org/10.1016/j.drugalcdep.2019.107563
  • Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017). Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine, 167(5), 293–301. https://doi.org/10.7326/M17-0865
  • Han, B., Compton, W. M., Jones, C. M., & Cai, R. (2015). Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. JAMA, 314(14), 1468–1478. https://doi.org/10.1001/jama.2015.11859
  • Harris, K. M., Halpern, C. T., Whitsel, E. A., Hussey, J. M., Killeya-Jones, L. A., Tabor, J., & Dean, S. C. (2019). Cohort profile: The National Longitudinal Study of Adolescent to Adult Health (Add Health). International Journal of Epidemiology, 48(5), 1415–1415k. https://doi.org/10.1093/ije/dyz115
  • Heitzeg, M. M., Cope, L. M., Martz, M. E., & Hardee, J. E. (2015). Neuroimaging risk markers for substance abuse: recent findings on inhibitory control and reward system functioning. [ReviewPaper]. Current Addiction Reports, 2(2), 91–103. https://doi.org/10.1007/s40429-015-0048-9
  • Hu, M.-C., Griesler, P., Wall, M., & Kandel, D. B. (2017). Age-related patterns in nonmedical prescription opioid use and disorder in the US population at ages 12–34 from 2002 to 2014. Drug and Alcohol Dependence, 177, 237–243. https://doi.org/10.1016/j.drugalcdep.2017.03.024
  • Jones, C. M. (2017). The paradox of decreasing nonmedical opioid analgesic use and increasing abuse or dependence – An assessment of demographic and substance use trends, United States, 2003–2014. Addictive Behaviors, 65, 229–235. https://doi.org/10.1016/j.addbeh.2016.08.027
  • Kennett, J., Painter, D., Hunter, S. R., Granger, R. A., Bowman, K. R. (2010). Assessing the reliability of key measures in the National Survey on Drug Use and Health using a test-retest methodology. https://www.samhsa.gov/data/sites/default/files/2k6ReliabilityP/2k6ReliabilityP.pdf
  • Marsh, J. C., Park, K., Lin, Y.-A., & Bersamira, C. (2018). Gender differences in trends for heroin use and nonmedical prescription opioid use, 2007-2014. Journal of Substance Abuse Treatment, 87, 79–85. https://doi.org/10.1016/j.jsat.2018.01.001
  • Martin, G., Vallance, K., Macdonald, S., Stockwell, T., Ivsins, A., Chow, C., Michelow, W., & Duff, C. (2014). Nonfatal overdose from alcohol and/or drugs among a sample of recreational drug users. Journal of Substance Use, 19(3), 239–244. https://doi.org/10.3109/14659891.2013.784369
  • Martins, S. S., Segura, L. E., Santaella-Tenorio, J., Perlmutter, A., Fenton, M. C., Cerdá, M., Keyes, K. M., Ghandour, L. A., Storr, C. L., & Hasin, D. S. (2017). Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014. Addictive Behaviors, 65, 236–241. https://doi.org/10.1016/j.addbeh.2016.08.033
  • Moffitt, T. E. (2018). Male antisocial behaviour in adolescence and beyond. Nature Human Behaviour, 2(3), 177–186. https://doi.org/10.1038/s41562-018-0309-4
  • Mojtabai, R. (2018). National trends in long‐term use of prescription opioids. Pharmacoepidemiology and Drug Safety, 27(5), 526–534. https://doi.org/10.1002/pds.4278
  • Mojtabai, R., Olfson, M., & Han, B. (2016). National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics, 138(6), e20161878–e20161878. https://doi.org/10.1542/peds.2016-1878
  • Olfson, M., Wang, S., Wall, M. M., & Blanco, C. (2020). Trends in opioid prescribing and self-reported pain among US adults: As efforts to curb inappropriate opioid prescribing continue, an examination of trends in short-term and longer-term opioid prescriptions for US adults who self-report various pain levels. Health Affairs (Project Hope), 39(1), 146–154. https://doi.org/10.1377/hlthaff.2019.00783
  • Ranade, R., Wunder, J., Terzian, M., & Ungureanu, I. (2020). Opioids and suicide: Opportunities for comprehensive prevention. Journal of Public Health Management and Practice, 26(3), 291–293. https://doi.org/10.1097/PHH.0000000000001161
  • Shanahan, L., Hill, S. N., Gaydosh, L. M., Steinhoff, A., Costello, E. J., Dodge, K. A., Harris, K. M., & Copeland, W. E. (2019). Does despair really kill? A roadmap for an evidence-based answer. American Journal of Public Health, 109(6), 854–858. https://doi.org/10.2105/AJPH.2019.305016
  • Thomas, D. A., Maslin, B., Legler, A., Springer, E., Asgerally, A., & Vadivelu, N. (2016). Role of alternative therapies for chronic pain syndromes. Current Pain and Headache Reports, 20(5), 29 https://doi.org/10.1007/s11916-016-0562-z
  • Ulirsch, J. C., Weaver, M. A., Bortsov, A. V., Soward, A. C., Swor, R. A., Peak, D. A., … Domeier, R. M. (2014). No man is an island: Living in a disadvantaged neighborhood influences chronic pain development after motor vehicle collision. Pain, 155(10), 2116–2123.
  • Wakeman, S. E., Rigotti, N. A., Chang, Y., Herman, G. E., Erwin, A., Regan, S., & Metlay, J. P. (2019). Effect of integrating substance use disorder treatment into primary care on inpatient and emergency department utilization. Journal of General Internal Medicine, 34(6), 871–877. https://doi.org/10.1007/s11606-018-4807-x
  • Wasserstein, R. L., & Lazar, N. A. (2016). The ASA statement on p-values: Context, process, and purpose. The American Statistician, 70(2), 129–133. https://doi.org/10.1080/00031305.2016.1154108

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.